POLYOMAVIRUS-ASSOCIATED NEPHROPATHY

This adverse event was reported 1388 times

These drugs are most commonly taken by patients reporting POLYOMAVIRUS-ASSOCIATED NEPHROPATHY:

# Drug Count
0 TACROLIMUS 1112
1 TACROLIMUS CAPSULES 1010
2 MYCOPHENOLATE MOFETIL 872
3 PREDNISONE 478
4 PREDNISOLONE 377
5 METHYLPREDNISOLONE 296
6 BASILIXIMAB 265
7 MYCOPHENOLIC ACID 168
8 VALGANCICLOVIR 155
9 VALGANCICLOVIR HYDROCHLORIDE 155
See all common drugs associated with POLYOMAVIRUS-ASSOCIATED NEPHROPATHY

POLYOMAVIRUS-ASSOCIATED NEPHROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE 1 0.0714
1 BASILIXIMAB 265 0.0340
2 CIDOFOVIR ANHYDROUS 30 0.0333
3 BRINCIDOFOVIR 2 0.0253
4 MYCOPHENILIC ACID 132 0.0152
5 TACROLIMUS CAPSULES 1010 0.0147
6 EVEROLIMUS TABLETS 140 0.0145
7 VALGANCICLOVIR 155 0.0133
8 ANTI-THYMOCYTE GLOBULIN (RABBIT) 80 0.0131
9 TACROLIMUS 1112 0.0112
See all drugs enriched for association with POLYOMAVIRUS-ASSOCIATED NEPHROPATHY